Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iva Gunnarsson

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Annals of Medicine|April 19, 2011
Biologicals for the treatment of systemic lupus erythematosus?Iva Gunnarsson, Ronald F van Vollenhoven
Clinical Kidney Journal|August 2, 2016
Ofatumumab treatment in lupus nephritis patientsMalena Loberg Haarhaus, Elisabet Svenungsson, Iva Gunnarsson
Frontiers in Immunology|February 4, 2022
Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the LiteratureSina Fuchs, Andrea Scheffschick, Iva Gunnarsson, et al.
Lupus|April 12, 2021
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosusKatarina Bremme, Sonja Honkanen, Iva Gunnarsson, et al.
Scandinavian Journal of Immunology|August 15, 2020
Proteinase 3 Autoreactivity in Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis-Immunological versus clinical featuresRavi K Sharma, Björn Lövström, Iva Gunnarsson, et al.
Arthritis Research & Therapy|December 17, 2009
Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritisChristopher Sjöwall, Agneta Zickert, Thomas Skogh, et al.
Clinical and Experimental Immunology|January 12, 2022
Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: presence, localization, and the effect of immunosuppressive treatmentAndrea Scheffschick, Sina Fuchs, Vivianne Malmström, et al.
Rheumatology Advances in Practice|November 13, 2023
How is the patient perspective captured in ANCA-associated vasculitis research? An integrative reviewAnnika Granath, Susanne Pettersson, Iva Gunnarsson, et al.
Clinical Rheumatology|September 29, 2020
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, et al.
Rheumatology (Oxford, England)|December 28, 2020
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatmentAgneta Zickert, Klas Lannfelt, Jan Schmidt Mende, et al.
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Annals of Medicine|April 19, 2011
Biologicals for the treatment of systemic lupus erythematosus?Iva Gunnarsson, Ronald F van Vollenhoven
Clinical Kidney Journal|August 2, 2016
Ofatumumab treatment in lupus nephritis patientsMalena Loberg Haarhaus, Elisabet Svenungsson, Iva Gunnarsson
Frontiers in Immunology|February 4, 2022
Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the LiteratureSina Fuchs, Andrea Scheffschick, Iva Gunnarsson, et al.
Lupus|April 12, 2021
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosusKatarina Bremme, Sonja Honkanen, Iva Gunnarsson, et al.
Scandinavian Journal of Immunology|August 15, 2020
Proteinase 3 Autoreactivity in Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis-Immunological versus clinical featuresRavi K Sharma, Björn Lövström, Iva Gunnarsson, et al.
Arthritis Research & Therapy|December 17, 2009
Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritisChristopher Sjöwall, Agneta Zickert, Thomas Skogh, et al.
Clinical and Experimental Immunology|January 12, 2022
Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: presence, localization, and the effect of immunosuppressive treatmentAndrea Scheffschick, Sina Fuchs, Vivianne Malmström, et al.
Rheumatology Advances in Practice|November 13, 2023
How is the patient perspective captured in ANCA-associated vasculitis research? An integrative reviewAnnika Granath, Susanne Pettersson, Iva Gunnarsson, et al.
Clinical Rheumatology|September 29, 2020
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, et al.
Rheumatology (Oxford, England)|December 28, 2020
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatmentAgneta Zickert, Klas Lannfelt, Jan Schmidt Mende, et al.
Pageof 20